These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 36828759)

  • 21. SIRT1 promotes epithelial-mesenchymal transition and metastasis in colorectal cancer by regulating Fra-1 expression.
    Cheng F; Su L; Yao C; Liu L; Shen J; Liu C; Chen X; Luo Y; Jiang L; Shan J; Chen J; Zhu W; Shao J; Qian C
    Cancer Lett; 2016 Jun; 375(2):274-283. PubMed ID: 26975631
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Cheng C; Huang Z; Zhou R; An H; Cao G; Ye J; Huang C; Wu D
    Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G841-G853. PubMed ID: 32146835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of parathyroid hormone-related peptide in the aggressive phenotype of colorectal cancer cells.
    Novoa Díaz MB; Carriere PM; Martín MJ; Calvo N; Gentili C
    World J Gastroenterol; 2021 Nov; 27(41):7025-7040. PubMed ID: 34887626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of nanotechnology in reversing therapeutic resistance and controlling metastasis of colorectal cancer.
    Ren SN; Zhang ZY; Guo RJ; Wang DR; Chen FF; Chen XB; Fang XD
    World J Gastroenterol; 2023 Apr; 29(13):1911-1941. PubMed ID: 37155531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic Targeting of the Tumour Microenvironment in Metastatic Colorectal Cancer.
    Dmello RS; To SQ; Chand AL
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current Progress of EMT: A New Direction of Targeted Therapy for Colorectal Cancer with Invasion and Metastasis.
    Tan Z; Sun W; Li Y; Jiao X; Zhu M; Zhang J; Qing C; Jia Y
    Biomolecules; 2022 Nov; 12(12):. PubMed ID: 36551152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KY1022, a small molecule destabilizing Ras via targeting the Wnt/β-catenin pathway, inhibits development of metastatic colorectal cancer.
    Cho YH; Cha PH; Kaduwal S; Park JC; Lee SK; Yoon JS; Shin W; Kim H; Ro EJ; Koo KH; Park KS; Han G; Choi KY
    Oncotarget; 2016 Dec; 7(49):81727-81740. PubMed ID: 27835580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epithelial-mesenchymal transition in colorectal cancer metastasis: A system review.
    Cao H; Xu E; Liu H; Wan L; Lai M
    Pathol Res Pract; 2015 Aug; 211(8):557-69. PubMed ID: 26092594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of snail induces epithelial-mesenchymal transition and a cancer stem cell-like phenotype in human colorectal cancer cells.
    Fan F; Samuel S; Evans KW; Lu J; Xia L; Zhou Y; Sceusi E; Tozzi F; Ye XC; Mani SA; Ellis LM
    Cancer Med; 2012 Aug; 1(1):5-16. PubMed ID: 23342249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LINC00543 promotes colorectal cancer metastasis by driving EMT and inducing the M2 polarization of tumor associated macrophages.
    Zheng J; Dou R; Zhang X; Zhong B; Fang C; Xu Q; Di Z; Huang S; Lin Z; Song J; Wang S; Xiong B
    J Transl Med; 2023 Feb; 21(1):153. PubMed ID: 36841801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The tumor microenvironment of colorectal cancer metastases: opportunities in cancer immunotherapy.
    Kamal Y; Schmit SL; Frost HR; Amos CI
    Immunotherapy; 2020 Oct; 12(14):1083-1100. PubMed ID: 32787587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer.
    Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J
    J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colorectal cancer-derived exosomal miR-106b-3p promotes metastasis by down-regulating DLC-1 expression.
    Liu H; Liu Y; Sun P; Leng K; Xu Y; Mei L; Han P; Zhang B; Yao K; Li C; Bai J; Cui B
    Clin Sci (Lond); 2020 Feb; 134(4):419-434. PubMed ID: 32065214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond.
    Al Bitar S; El-Sabban M; Doughan S; Abou-Kheir W
    World J Gastroenterol; 2023 Mar; 29(9):1395-1426. PubMed ID: 36998426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NFATc1 promotes epithelial-mesenchymal transition and facilitates colorectal cancer metastasis by targeting SNAI1.
    Shen T; Yue C; Wang X; Wang Z; Wu Y; Zhao C; Chang P; Sun X; Wang W
    Exp Cell Res; 2021 Nov; 408(1):112854. PubMed ID: 34597678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast Cancer Metastasis: Mechanisms and Therapeutic Implications.
    Park M; Kim D; Ko S; Kim A; Mo K; Yoon H
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of the sensitivity of metastatic colorectal cancer patients with deficient mismatch repair to standard-of-care chemotherapy and monoclonal antibodies, with recommendations for future research.
    Wensink E; Bond M; Kucukkose E; May A; Vink G; Koopman M; Kranenburg O; Roodhart J
    Cancer Treat Rev; 2021 Apr; 95():102174. PubMed ID: 33721596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical management of metastatic colorectal cancer in the era of precision medicine.
    Ciardiello F; Ciardiello D; Martini G; Napolitano S; Tabernero J; Cervantes A
    CA Cancer J Clin; 2022 Jul; 72(4):372-401. PubMed ID: 35472088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unraveling the function of epithelial-mesenchymal transition (EMT) in colorectal cancer: Metastasis, therapy response, and revisiting molecular pathways.
    Sabouni E; Nejad MM; Mojtabavi S; Khoshduz S; Mojtabavi M; Nadafzadeh N; Nikpanjeh N; Mirzaei S; Hashemi M; Aref AR; Khorrami R; Nabavi N; Ertas YN; Salimimoghadam S; Zandieh MA; Rahmanian P; Taheriazam A; Hushmandi K
    Biomed Pharmacother; 2023 Apr; 160():114395. PubMed ID: 36804124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.